As of 2025-09-19, the Fair Value of 4D Molecular Therapeutics Inc (FDMT) is -21.00 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.10 USD, the upside of 4D Molecular Therapeutics Inc is -395.78%.
With the market price of 7.10 USD and our fair value calculation, 4D Molecular Therapeutics Inc (FDMT) is not a good investment. Investing in FDMT stocks now will result in a potential loss of 395.78%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -56.69 | -71.32 | -107.49 | -100.84 | -160.87 | -99.44 |
| YoY growth | -14.97% | -25.81% | -50.72% | 6.19% | -59.53% | -28.97% |
| Market Cap (mil) | 331.57 |
| P/E | |
| Forward P/E |
| EPS | -4.20 |
| Avg earnings growth rate | -28.97% |
| TTM earnings | -196.14 |